Literature DB >> 23033178

Phenylketonuria, congenital hypothyroidism and haemoglobinopathies: public health issues for a Brazilian newborn screening program.

Judy Botler1, Luiz Antonio Bastos Camacho, Marly Marques da Cruz.   

Abstract

In this study, the frequency of detected congenital hypothyroidism, phenylketonuria and haemoglobinopathies in the State of Rio de Janeiro's (Brazil) Newborn Screening Program (NBSP) was analyzed between the years of 2005 and 2007. There were two Newborn Screening Reference Centers (named NSRC A and B) with programmatic differences. In 2007, overall detection coverage reached 80.7%. The increase in the incidence of congenital hypothyroidism (1:1,030 in 2007) was attributed to the reduction of neonatal TSH value limits over time. The incidence discrepancy of phenylketonuria between NSRC A (1:28,427) and B (1:16,522) might be partially explained by the small number of cases. The incidence of sickle cell disease and its traits were uniformly high (1:1,288 and 1:21, respectively). This was coherent with the ethnic composition of the population. The differences in laboratory methods and critical values, in addition to other programmatic issues, may explain the variances in the results and limited analysis of the role of biological and environmental determinants in the occurrence of these diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23033178     DOI: 10.1590/s0102-311x2012000900002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  9 in total

1.  Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Authors:  Têmis Maria Félix; Bibiana Mello de Oliveira; Milena Artifon; Isabelle Carvalho; Filipe Andrade Bernardi; Ida V D Schwartz; Jonas A Saute; Victor E F Ferraz; Angelina X Acosta; Ney Boa Sorte; Domingos Alves
Journal:  Orphanet J Rare Dis       Date:  2022-02-24       Impact factor: 4.123

2.  Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis.

Authors:  Pamela K Foreman; Andrea V Margulis; Kimberly Alexander; Renee Shediac; Brian Calingaert; Abenah Harding; Manel Pladevall-Vila; Sarah Landis
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

3.  Prevalence of neonatal hyperphenylalaninemia in yazd province, iran.

Authors:  Mahtab Ordooei; Majid Jafarizadeh; Mohsen Mirzaei; Hasan Ashoori; Ali Zare; Hossein Shojaeifar
Journal:  Iran J Med Sci       Date:  2015-05

Review 4.  Need for neonatal screening program in India: A national priority.

Authors:  Neha Sareen; Ritu Pradhan
Journal:  Indian J Endocrinol Metab       Date:  2015 Mar-Apr

5.  Incidence of sickle cell disease and other hemoglobin variants in 10,095 Lebanese neonates.

Authors:  Evelyne Khoriaty; Rim Halaby; Mohamad Berro; Ahmad Sweid; Hussein A Abbas; Adlette Inati
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

6.  Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis.

Authors:  Hamid Reza Shoraka; Ali Akbar Haghdoost; Mohammad Reza Baneshi; Zohre Bagherinezhad; Farzaneh Zolala
Journal:  Clin Exp Pediatr       Date:  2020-02-06

7.  Changes in the incidence and etiology of congenital hypothyroidism detected during 30 years of a screening program in central Serbia.

Authors:  Katarina Mitrovic; Rade Vukovic; Tatjana Milenkovic; Sladjana Todorovic; Jovana Radivojcevic; Dragan Zdravkovic
Journal:  Eur J Pediatr       Date:  2015-09-07       Impact factor: 3.183

8.  Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.

Authors:  E Vieira; H S Maia; C B Monteiro; L M Carvalho; T Tonon; A P Vanz; I V D Schwartz; M G Ribeiro
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

9.  Mutation analysis of the PAH gene in phenylketonuria patients from Rio de Janeiro, Southeast Brazil.

Authors:  Eduardo Vieira Neto; Francisco Laranjeira; Dulce Quelhas; Isaura Ribeiro; Alexandre Seabra; Nicole Mineiro; Lilian D M Carvalho; Lúcia Lacerda; Márcia G Ribeiro
Journal:  Mol Genet Genomic Med       Date:  2018-05-10       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.